Clinical Trials Directory

Trials / Terminated

TerminatedNCT04510467

Mental Health Consequences of COVID19 Infection in the French RMD Cohort

Mental Health Consequences of COVID19 Infection in the French Rheumatic Musculoskeletal Diseases (RMD) Cohort

Status
Terminated
Phase
Study type
Observational
Enrollment
296 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

this observational, cross-sectional, national, comparative study, including RMD patients followed in hospital centres of the FAI²R Rare Diseases Healthcare Pathway network and specialist private practitioners caring for patients suffering from inflammatory rheumatism, systemic autoimmune diseases and auto-inflammatory diseases. The objective of the study is to compare RMD patients with COVID 19 infection (cases) to RMD patients who have not had COVID 19 infection (controls) on their mental health.

Conditions

Timeline

Start date
2021-01-20
Primary completion
2022-05-19
Completion
2022-05-19
First posted
2020-08-12
Last updated
2023-01-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04510467. Inclusion in this directory is not an endorsement.